Literature DB >> 21598993

A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.

Weiping Liu1, Xizhu Chen, Qingsong Ye, Yongping Xu, Chengying Xie, Mingjin Xie, Qiaowen Chang, Liguang Lou.   

Abstract

A novel water-soluble heptaplatin analogue, cis-[(4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3-dioxolane](3-hydroxy-1,1-cyclobutanedicarboxylato)platinum(II), has been synthesized and biologically evaluated. The complex shows more activity and less toxicity than its parent drug heptaplatin, exhibiting the great potential for further development.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598993     DOI: 10.1021/ic200436u

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  3 in total

1.  In vitro anticancer activity of cis-diammineplatinum(II) complexes with β-diketonate leaving group ligands.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  J Med Chem       Date:  2012-05-18       Impact factor: 7.446

2.  Two mixed-NH3/amine platinum (II) anticancer complexes featuring a dichloroacetate moiety in the leaving group.

Authors:  Weiping Liu; Jia Su; Jing Jiang; Xingyao Li; Qingsong Ye; Hongyu Zhou; Jialin Chen; Yan Li
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

3.  Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance.

Authors:  Xixi Lin; Yongliang Jia; Xinwei Dong; Jian Shen; Yachao Jin; Yanyou Li; Fang Wang; Eitan Anenberg; Jiancang Zhou; Jianping Zhu; Xiaoping Chen; Qiangmin Xie; Yicheng Xie
Journal:  Front Pharmacol       Date:  2019-09-11       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.